|
1）Shultz LD, Ishikawa F, Greiner DL. Humanized mice in translational biomedical research. Nat Rev Immunol. 2007; 7: 118-30
|
|
|
|
2）McCune JM, Namikawa R, Kaneshima H, et al. The SCID-hu mouse: murine model for the analysis of human hematolymphoid differentiation and function. Science. 1988; 241: 1632-9
|
|
|
|
|
3）Kimura T, Asada R, Wang J, et al. Identification of long-term repopulating potential of human cord blood-derived CD34-flt3- severe combined immunodeficiency-repopulating cells by intra-bone marrow injection. Stem Cells. 2007; 25: 1348-55
|
|
|
|
|
|
4）Traggiai E, Chicha L, Mazzucchelli L, et al. Development of a human adaptive immune system in cord blood cell-transplanted mice. Science. 2004; 304: 104-7
|
|
|
|
|
|
5）Ishikawa F, Livingston AG, Wingard JR, et al. An assay for long-term engrafting human hematopoietic cells based on newborn NOD/SCID/beta2-microglobulin(null) mice. Exp Hematol. 2002; 30: 488-94
|
|
|
|
|
|
6）Ishikawa F, Yasukawa M, Lyons B, et al. Development of functional human blood and immune systems in NOD/SCID/IL2 receptor {gamma} chain(null) mice. Blood. 2005; 106: 1565-73
|
|
|
|
|
|
7）Suda T, Arai F, Hirao A. Hematopoietic stem cells and their niche. Trends Immunol. 2005; 26: 426-33
|
|
|
|
|
|
8）Sugiyama T, Kohara H, Noda M, et al. Maintenance of the hematopoietic stem cell pool by CXCL12-CXCR4 chemokine signaling in bone marrow stromal cell niches. Immunity. 2006; 25: 977-88
|
|
|
|
|
|
9）Wang J, Kimura T, Asada R, et al. SCID-repopulating cell activity of human cord blood-derived CD34- cells assured by intra-bone marrow injection. Blood. 2003; 101: 2924-31
|
|
|
|
|
|
10）Hiramatsu H, Nishikomori R, Heike T, et al. Complete reconstitution of human lymphocytes from cord blood CD34＋ cells using the NOD/SCID/gammacnull mice model. Blood. 2003; 102: 873-80
|
|
|
|
|
|
11）Ishikawa F, Niiro H, Iino T, et al. The developmental program of human dendritic cells is operated independently of conventional myeloid and lymphoid pathways. Blood. 2007; 110: 3591-660
|
|
|
|
|
|
12）Baenziger S, Tussiwand R, Schlaepfer E, et al. Disseminated and sustained HIV infection in CD34＋ cord blood cell-transplanted Rag2-/-gamma c-/- mice. Proc Natl Acad Sci USA. 2006; 103: 15951-6
|
|
|
|
|
|
13）Kawano N, Ishikawa F, Shimoda K, et al. Efficient engraftment of primary adult T-cell leukemia cells in newborn NOD/SCID/beta2-microglobulin(null) mice. Leukemia. 2005; 19: 1384- 90
|
|
|
|
|
|
14）Miyazato P, Yasunaga J, Taniguchi Y, et al. De novo human T-cell leukemia virus type 1 infection of human lymphocytes in NOD-SCID, common gamma-chain knockout mice. J Virol. 2006; 80: 10683-91
|
|
|
|
|
|
15）Matsuoka M, Jeang KT. Human T-cell leukaemia virus type 1 (HTLV-1) infectivity and cellular transformation. Nat Rev Cancer. 2007; 7: 270-80
|
|
|
|
|
|
16）Lapidot T, Sirard C, Vormoor J, et al. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature. 1994; 367: 645-8
|
|
|
|
|
|
17）Pearce DJ, Taussig D, Zibara K, et al. AML engraftment in the NOD/SCID assay reflects the outcome of AML: implications for our understanding of the heterogeneity of AML. Blood. 2006; 107: 1166-73
|
|
|
|
|
|
18）Lumkul R, Gorin NC, Malehorn MT, et al. Human AML cells in NOD/SCID mice: engraftment potential and gene expression. Leukemia. 2002; 16: 1818-26
|
|
|
|
|
|
19）Singh SK, Hawkins C, Clarke ID, et al. Identification of human brain tumour initiating cells. Nature. 2004; 432: 396-401
|
|
|
|
|
|
20）O'Brien CA, Pollett A, Gallinger S, et al. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature. 2007; 445: 106-10
|
|
|
|
|
|
21）Al-Hajj M, Wicha MS, Benito-Hernandez A, et al. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA. 2003; 100: 3983-8
|
|
|
|
|